The science of treating opioid addiction has become increasingly popular in both medical circles and in the addiction treatment community.

For decades, medical professionals and even popular recovery organizations did not quite understand how giving an opioid addict a replacement medication could actually facilitate recovery.

Part of the dilemma was that those who defined “recovery” did so using an old school philosophical approach originally crafted for alcoholism. But science has taught us that not all addictions are exactly the same. While there are certainly commonalities between the various substance use disorders, there are very important distinctions and differences which affect the recovery process.

You cannot prescribe a medication that is effective with depression, and expect that same medication to resolve schizophrenia or an anxiety disorder. While they are all mental health disorders that can debilitate a patient, there are critical differences between these disorders and in the overall treatment plan for addressing each one.

Similarly with addiction, science is teaching us that a one-size-fits-all approach to addiction recovery is detrimental and often unproductive.

With opioid addiction in particular, the disease progression is quite unlike most other addictive illnesses. While the medical profession has evolved that understanding, the recovery community and general society has at times struggled to comprehend the necessity of medication-assisted treatment for the opioid addicted.

Physicians, Nurse Practitioners, PA’s, Nurses, and Counselors all play a part in educating patients, their families, the community, and government on the key role that medication plays in the successful management of an opioid use disorder. Methadone, subutex, suboxone, vivitrol, and other medication choices make the difference between recovery success and repeated recovery failures.

Various news outlets are reporting new statistics which indicate deaths from opioid overdose are beginning to go down.

The Associated Press reports that for the first time in a decade overdoses among New York residents (outside of NYC) have declined 15.9%. Government officials are quoted as saying that about 80% of the overdose deaths were attributable to heroin or fentanyl.

The AP cited a new CDC (Centers For Disease Control) July 2019 study which showed overdose deaths in 2018 fell for the first time in nearly three decades.

Various public education efforts and New York’s Opioid Task Force are thought to be significant catalysts for the slowdown in opioid overdoses. The availability of naloxone has also been highly instrumental in impacting overdoses nationwide with many communities across the country now providing naloxone kits for free.

A number of metro areas in the U.S. are also examining the feasibility of mobile opioid treatment since transportation to clinics or physicians is often an impediment to accessing medication-assisted treatment resources.

Behavioral Health Group (BHG) currently provides 58 top flight opioid addiction treatment centers in the United States. The company specializes in medication-assisted treatment using methadone, buprenorphine, and buprenorphine/naloxone.

BHG takes a patient-centered approach to treating addictive disorders offering counseling as a fundamental component of the overall treatment model. Because of this individualized treatment approach, 97% of patients surveyed indicate they would recommend BHG Recovery to a friend or family member suffering from opioid addiction.

Additionally, 99% of patients report that their mental health and quality of life improved since their BHG admission. 60% of unemployed patients were able to obtain employment after one year of treatment.

Hope, Respect, and Caring are tenets of BHG’s treatment program, and their staff strive to provide this from the moment a patient first walks in to receive help. All of BHG’s treatment centers provide care in an outpatient setting.

In 2019 and 2020, BHG Recovery added (10) additional U.S. clinics to the Methadone.US national directory list …

1. Franklin, VA – BHG Franklin Treatment Center
2. Chesapeake, VA – BHG Chesapeake South Treatment Center
3. Glen Allen, VA – BHG Glen Allen Treatment Center
4. Mobile, AL – BHG Mobile Treatment Center
5. Cullman, AL – BHG Cullman Treatment Center
6. Washington, DC – BHG Washington DC Treatment Center
7. Colorado Springs, CO – BHG Colorado Springs Treatment Center
8. Grand Bay, AL – BHG Grand Bay Treatment Center
9. North Little Rock, AR – BHG North Little Rock Treatment Center
10. Savannah, TN – BHG Savannah Treatment Center

Recovery from opioid addiction initially centers around physical stabilization: specifically the management of opioid withdrawal. This is an essential step for the vast majority of opioid addicted people seeking help. Research has shown a 90% failure rate for opioid treatment programs that do not offer medication assistance.

Methadone was the original medication FDA-approved for treating opioid addiction although Subutex has been recently introduced into opioid treatment programs around the country as a viable alternative. Subutex is effective especially for milder levels of opioid dependency.

Subutex is a brand name version of buprenorphine, the partial opioid agonist that reduces withdrawal symptom sickness. Most patients are familiar with “Suboxone” which is a popular buprenorphine-based film that is dissolved under the tongue and is taken once per day. It differs from Subutex in that it contains naloxone so that it cannot be easily abused intravenously.

A number of methadone clinics began offering subutex in the past few years in an effort to expand treatment options for patients. Because subutex can be abused, it is typically administered daily in the clinic by a nurse where it can be supervised.

If you are considering entering a treatment program for opioid misuse, you may want to ask about the variety of medications utilized by the clinic or physician. Some patients have successfully transitioned from methadone to subutex while others enter the program starting with subutex. This is a decision best made in conjunction with your treating doctor who can formulate a treatment plan based on your history of opioid use.